The Lancet | The best science for better lives
WEBSep 13, 2024 · Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Oncology. 02 Aug 2024.
The Lancet: Journal Homepage
WEB4 days ago · The growing challenge of antimicrobial resistance (AMR) is now recognised as a global public health emergency that requires concerted efforts by all stakeholders. 1 There is compelling evidence that AMR is associated with increased mortality and longer hospitalisation, and has a negative effect on the economies of communities and …
The Lancet, 14 September 2024, Volume 404, Issue 10457, Pages …
WEB6 days ago · Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up. Holger Thiele, Jacob E Møller, Jose P S Henriques, Margriet Bogerd, Melchior Seyfarth, Daniel Burkhoff, Petr Ostadal,
The Lancet Oncology
WEB5 days ago · In 2015, the Lancet Oncology Commission on Global Cancer Surgery focused on access to safe, affordable, and timely cancer surgery worldwide. It highlighted cancer surgery as integral to national cancer control plans and critically examined the state of global cancer surgery and changes in policy that might drive improvements in research, …
The Lancet Microbe Home Page
WEB2 days ago · Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Zoe Dyson and Dr Philip Ashton about the genomic characterisation of population diversity, antimicrobial resistance profiles, and transmission patterns of Salmonella enterica serotypes Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi. Read associated article. (mp3, …
Divisions over lecanemab: keeping an open mind - The Lancet
WEB11 hours ago · After more than a century since Alois Alzheimer's description of an “unusual illness of the cerebral cortex”, the development of drugs to alter the course of Alzheimer's disease is a monumental advance. Yet, access to lecanemab—the first disease-modifying drug for the disease—has been approved in some regions and refused in others, …
Antimicrobial resistance: a concise update - The Lancet Microbe
WEB2 days ago · Antimicrobial resistance (AMR) is a serious threat to global public health, with approximately 5 million deaths associated with bacterial AMR in 2019. Tackling AMR requires a multifaceted and cohesive approach that ranges from increased understanding of mechanisms and drivers at the individual and population levels, AMR surveillance, …
Next-generation influenza vaccines based on mRNA technology
WEB2 days ago · Thus, in The Lancet Infectious Diseases, Dense Hsu and colleagues 8 report the interim results of a safety and immunogenicity study of a panel of next-generation mRNA influenza vaccines that targeted an additional one or two influenza H3N2 strains in adults aged 50–75 years. All vaccines included the A/Darwin/6/2021 (H3N2) strain …
About The Lancet medical journal
WEBThe Lancet is a world-leading source of clinical, public health, and global health knowledge. The journal has an Impact Factor of 98·4, ranking first among 325 general and internal medicine journals globally (2023 Journal Citation Reports ®, Clarivate 2024), and a CiteScore of 148·1, ranking first among 636 general medicine journals (Scopus).
The Lancet Commission on 21st-Century Global Health Threats
WEBThe world has lived through an extraordinary global health threat, the COVID-19 pandemic, leading to nearly 20 million deaths, staggering economic losses, a generational decline in human capital, and the first decline in global life expectancy since 1950 (the first year when UN estimates were published).1–4 Another major threat, climate change, now has broad …